Free Republic

CHICAGO – A five-minute, point-of-care coronavirus test could be coming to urgent care clinics next week, and experts say it could be "game-changing." The U.S. Food and Drug Administration issued Emergency Use Authorization to Illinois-based medical device maker Abbott Labs on Friday for a coronavirus test that delivers positive results in as little as five minutes and negative results in 13 minutes, the company said. The company expects the tests to be available next week and expects to ramp up manufacturing to deliver 50,000 tests per day. "I am pleased that the FDA authorized Abbott's point-of-care test yesterday. This is...

- The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines - Test to run on Abbott's point-of-care ID NOW platform - a portable instrument that can be deployed where testing is needed most - ID NOW has the largest molecular point-of-care installed base in the U.S. and is available in a wide range of healthcare settings - Abbott will be making ID NOW COVID-19 tests available next week and expects to ramp up manufacturing to deliver 50,000 tests per day - This is the company's second test to receive Emergency Use Authorization by the FDA for...